V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10444165 | 10065174 | 1.69 | 84.7 | null | 2019-06-28 | 2019-07-05 | FEC + DOCETAXEL | 02 | null | CARBOPLATIN + DOCETAXEL | 100926689 |
| 10444458 | 10065175 | 1.79 | 95 | Palliative (P) | 2021-05-11 | 2021-05-17 | CAPECITABINE + CARBOPLATIN | 02 | N | NAB-PACLITAXEL | 100069269 |
| 10444464 | 10065176 | 1.8 | 62.2 | null | 2017-11-11 | 2017-11-16 | OSIMERTINIB | 02 | null | APALUTAMIDE | 101142185 |
| 10444733 | 10065177 | null | null | null | 2020-02-19 | 2020-02-26 | PCV | 02 | null | CARBOPLATIN + PEMBROLIZUMAB + PEMETREXED | 100441369 |
| 10444770 | 10065178 | 0 | 71.8 | null | 2021-07-11 | 2021-07-25 | ICE-R (Cycle 2 onwards) | 02 | null | CAPECITABINE + CISPLATIN | 101371771 |
| 10444972 | 10065179 | 1.72 | 108.3 | Adjuvant (A) | 2022-02-08 | 2022-02-16 | OSIMERTINIB | 02 | N | IBRUTINIB + RITUXIMAB | 100146882 |
| 10445052 | 10065180 | 1.56 | 66 | Palliative (P) | 2016-03-04 | 2016-03-27 | VISMODEGIB | N | N | FLUOROURACIL + MITOMYCIN | 100674598 |
| 10445399 | 10065184 | 0 | 59 | Palliative (P) | 2019-01-27 | 2019-01-27 | EVEROLIMUS + EXEMESTANE | 02 | N | LENALIDOMIDE + RITUXIMAB | 100709390 |
| 10445930 | 10065189 | null | 56.1 | null | 2021-06-18 | 2021-06-18 | BCG Intravesical | 02 | null | CYCLOPHOSPHAMIDE + RITUXIMAB | 100953445 |
| 10446238 | 10065190 | 1.64 | 68.65 | Palliative (P) | 2020-01-04 | 2020-01-16 | EVEROLIMUS | 02 | N | CHOP R | 100610272 |
| 10446335 | 10065191 | 1.82 | 60.4 | null | 2019-09-09 | 2020-10-09 | EC | 02 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101013370 |
| 10446774 | 10065193 | 1.69 | 59 | Palliative (P) | 2018-11-23 | 2018-11-23 | null | 02 | N | CYCLOPHOSPHAMIDE + ETOPOSIDE + RITUXIMAB + VINCRISTINE | 100027111 |
| 10447365 | 10065197 | 1.59 | 72.1 | Neo-adjuvant (N) | 2019-12-28 | 2019-12-31 | null | 02 | N | LOMUSTINE + PROCARBAZINE + VINCRISTINE | 100578787 |
| 10447630 | 10065198 | 1.7 | 97.3 | null | 2017-04-17 | 2017-04-25 | Busulfan Oral | 02 | null | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101196709 |
| 10447813 | 10065199 | 1.69 | 0 | null | null | 2020-06-25 | Durvalumab | null | null | CAPECITABINE + CARBOPLATIN | 100270622 |
| 10448167 | 10065202 | 1.85 | 43.5 | 03 | 2018-12-21 | 2019-01-25 | Erlotinib | 02 | N | EVEROLIMUS | 100768880 |
| 10448389 | 10065205 | 1.58 | 89.3 | Palliative (P) | 2021-08-12 | 2021-08-14 | CYCLOPHOSPHAMIDE + THALIDOMIDE | 02 | N | THALIDOMIDE | 100532477 |
| 10448427 | 10065206 | 1.82 | 78 | Palliative (P) | 2019-02-07 | 2019-02-08 | ISATUXIMAB + POMALIDOMIDE | 02 | N | CISPLATIN + FLUOROURACIL | 100597119 |
| 10448603 | 10065207 | 1.77 | 67.3 | null | 2018-03-16 | 2018-03-23 | CLARITY Trial | N | null | NERATINIB | 100765545 |
| 10449361 | 10065210 | 1.55 | 69.5 | null | 2020-02-03 | 2020-04-20 | null | 02 | null | LENALIDOMIDE + RITUXIMAB | 101620296 |
| 10449561 | 10065211 | 1.73 | 60.4 | null | 2018-05-22 | 2020-04-15 | Gemcitabine + Oxaliplatin | 02 | N | LETROZOLE + PALBOCICLIB | 100469931 |
| 10449977 | 10065212 | 1.81 | 72.5 | null | 2017-12-22 | 2018-03-22 | Docetaxel + nintedanib | 02 | null | FULVESTRANT + PALBOCICLIB | 101325616 |
| 10450327 | 10065214 | 1.73 | 83 | null | 2021-02-17 | 2021-03-14 | Ipilimumab | 02 | null | OBINUTUZUMAB | 100638667 |
| 10450664 | 10065216 | 1.78 | 83.8 | Palliative (P) | 2020-02-09 | 2020-02-23 | INTERFERON | 02 | N | OBINUTUZUMAB | 100421788 |
| 10451435 | 10065217 | null | null | Palliative (P) | 2019-08-22 | 2019-08-30 | GEMCITABINE + TREOSULPHAN | 02 | N | LETROZOLE + PALBOCICLIB | 100533230 |
| 10451466 | 10065218 | 0 | 77 | null | 2019-08-05 | 2019-08-23 | null | 02 | null | CTD | 101657859 |
| 10451525 | 10065219 | 1.52 | 67.7 | Curative (C) | 2022-01-21 | 2022-01-21 | Topotecan (oral) | null | N | DOCETAXEL + TRASTUZUMAB | 101813115 |
| 10451574 | 10065220 | 0 | 0 | 03 | 2019-10-11 | 2019-10-11 | Ixazomib | 02 | N | CISPLATIN + CYCLOPHOSPHAMIDE + CYTARABINE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101833820 |
| 10451796 | 10065223 | 1.75 | 53.8 | null | 2019-12-14 | 2019-12-14 | CHLORAMBUCIL + ETOPOSIDE + LOMUSTINE | 02 | null | CARBOPLATIN + DOCETAXEL + TRASTUZUMAB | 100355081 |
| 10451938 | 10065224 | 0 | 0 | null | null | 2019-09-23 | R CODOX-M/ R IVAC | 02 | null | R CODOX-M/ R IVAC | 100580358 |
| 10452468 | 10065226 | 1.58 | 89.3 | null | 2018-05-16 | 2019-11-22 | Capecitabine + Cisplatin | 02 | null | CYCLOPHOSPHAMIDE + CYTARABINE + DOXORUBICIN + METHOTREXATE + RITUXIMAB + VINCRISTINE | 100730289 |
| 10452501 | 10065227 | 1.67 | 75.8 | Palliative (P) | 2018-03-22 | 2018-05-15 | MUK 9 TRIAL | 02 | N | ERLOTINIB | 100847502 |
| 10454229 | 10065229 | 1.88 | 82.7 | null | 2017-09-05 | 2017-09-12 | null | 02 | N | FLAIR TRIAL | 101420082 |
| 10454575 | 10065231 | 1.8 | 68.2 | Palliative (P) | 2016-01-18 | 2017-10-20 | Fulvestrant + Ribociclib | 02 | N | DURVALUMAB | 101407185 |
| 10454721 | 10065232 | 1.76 | 74.4 | Curative (C) | 2022-02-06 | 2022-02-13 | null | 02 | N | VISMODEGIB | 101295477 |
| 10454792 | 10065233 | null | null | null | 2018-08-23 | 2018-08-31 | BOSUTINIB | 02 | null | ERIBULIN | 101314395 |
| 10455322 | 10065237 | 1.53 | 85.4 | 03 | 2018-03-27 | 2018-03-27 | Midostaurin | 02 | N | DURVALUMAB | 100027122 |
| 10455346 | 10065238 | 1.83 | 88.3 | null | 2018-12-29 | 2019-01-26 | CYCLOPHOSPHAMIDE + POMALIDOMIDE | 02 | null | BLEOMYCIN | 101620200 |
| 10455491 | 10065239 | null | null | null | 2018-10-26 | 2018-11-16 | Vinblastine | 02 | null | CAPECITABINE + OXALIPLATIN + TRASTUZUMAB | 100792335 |
| 10455582 | 10065240 | null | null | null | 2021-08-24 | 2021-09-01 | null | 02 | N | CYTARABINE + RITUXIMAB | 101346254 |
| 10455599 | 10065241 | 0 | 77.5 | null | 2020-01-12 | 2020-02-10 | Olaparib | 02 | null | DOXORUBICIN + OLARATUMAB | 101486861 |
| 10456186 | 10065242 | 1.67 | 70 | null | 2019-04-28 | 2019-07-21 | Trastuzumab(Kadcyla®) (1st cycle) | 02 | null | BENDAMUSTINE | 100520601 |
| 10456315 | 10065243 | 1.78 | 82.1 | null | 2020-11-29 | 2020-12-03 | PEG INTERFERON | 02 | null | BEXAROTENE | 100751880 |
| 10456500 | 10065244 | 1.77 | 74 | null | 2019-06-20 | 2019-06-28 | Mitomycin Intravesical | 02 | null | CARBOPLATIN + FLUOROURACIL | 101412367 |
| 10456807 | 10065247 | 1.69 | 0 | Palliative (P) | 2019-11-18 | 2019-12-06 | FLUOROURACIL + OXALIPLATIN | 02 | N | FLUOROURACIL + MITOMYCIN | 101200136 |
| 10456923 | 10065248 | 1.75 | 91.7 | Palliative (P) | 2019-11-04 | 2020-05-05 | null | 02 | N | CYCLOPHOSPHAMIDE + GEMCITABINE + RITUXIMAB + VINCRISTINE | 100001107 |
| 10457185 | 10065249 | 0 | 71.78 | 03 | 2016-11-25 | 2018-10-09 | null | 02 | null | DOCETAXEL + GEMCITABINE | 101304930 |
| 10457867 | 10065251 | 0 | 63.7 | null | 2019-09-10 | 2020-05-15 | MELPHALAN + THALIDOMIDE | 02 | null | DOCETAXEL + NINTEDANIB | 100435008 |
| 10458219 | 10065253 | 1.87 | 41 | Curative (C) | null | 2021-10-20 | CHLORAMBUCIL + ETOPOSIDE + LOMUSTINE | 02 | 2 | ANAGRELIDE | 100775748 |
| 10458629 | 10065254 | null | null | null | 2019-12-04 | 2020-01-12 | null | 02 | null | BEXAROTENE | 100675885 |